Find Academic Supervisors

Anton DvorzhakView profile

Researcher

• Neuroscience
• Neurophysiology
• Synaptic Plasticity
• +3 more

Dr. Anton Dvorzhak is a neuroscience researcher at the Institute of Neurophysiology, Faculty of Medicine, Charité - Universitätsmedizin Berlin, actively contributing to Collaborative Research Center 1315 (SFB 1315). His work focuses on the neural mechanisms underlying memory formation, synaptic plasticity, and social behavior, particularly examining hippocampal neuron dynamics and periaqueductal gray function. His research interests center on hippocampal oscillations during memory processes , synaptic transmission mechanisms , and the neurobiological basis of social play behavior . Using advanced techniques including 2-photon imaging, optogenetics, and electron microscopy, his work bridges cellular neuroscience with behavioral outcomes, particularly investigating how neurotransmitter systems like glycine regulate age-dependent changes in play behavior. Analysis of his recent publications reveals a strong focus on subcortical mechanisms of social behavior , with particular emphasis on the periaqueductal gray's role in play and tickling responses. His work demonstrates how specific neural columns within this region map to distinct behavioral responses, and how glycine modulation can reverse age-related declines in social play. His cellular neuroscience work shows how synaptic ultrastructure rapidly remodels during presynaptic potentiation, providing structural correlates for functional changes in synaptic strength.

Joakim BergströmView profile

Researcher

• Neurodegenerative Diseases
• Parkinson's Disease Research
• Alpha-Synuclein Pathology
• +4 more

Joakim Bergström serves as an Associate Researcher at Uppsala University's Department of Public Health and Care Sciences within the Faculty of Medicine, specifically at the Molecular Geriatrics/Rudbeck Laboratory. He concurrently holds a Research Advisor position at the University Administration's Office of Medicine and Pharmacy. Faculty of Medicine, Uppsala University Department of Public Health and Care Sciences Molecular Geriatrics/Rudbeck Laboratory Office of Medicine and Pharmacy (Research Support Unit) His primary research focuses on alpha-synuclein pathology mechanisms in Parkinson's disease, with particular emphasis on oligomer formation, propagation pathways, and immunotherapeutic interventions. Bergström investigates how alpha-synuclein aggregates interact with cellular components like SNARE proteins and glial cells, and develops antibody-based strategies to mitigate neurodegeneration in transgenic models. Analysis of his 15 most recent publications reveals consistent investigation of alpha-synuclein oligomerization mechanisms, transgenic mouse modeling of Parkinson's symptoms, and therapeutic antibody development. His work spans molecular neuroscience, neuroimmunology, and translational neuropharmacology, with increasing focus on imaging techniques and cross-amyloid interactions in recent years. Bergström actively collaborates with leading researchers in the field including Martin Ingelsson, Veronica Lindström, and Gunilla Westermark, contributing to studies that bridge basic molecular mechanisms with potential clinical applications for synucleinopathies.

Ole KjærulffView profile

Associate Professor

• Neuroscience
• Molecular Biology
• Synaptic Transmission
• +5 more

Ole Kjærulff is an Associate Professor in the Department of Neuroscience at the Faculty of Health and Medical Sciences, University of Copenhagen. His research primarily focuses on molecular mechanisms of cell communication in the nervous system, with particular emphasis on synaptic transmission processes and axonal transport. Dr. Kjærulff's research laboratory investigates how cells in the nervous system communicate with each other, with specific interest in synaptic transmission where nerve cells communicate by releasing signaling molecules (neurotransmitters) at specialized contact points called synapses. His current research focuses on peptides as signaling molecules, which consist of short amino acid chains. His team examines how dense core vesicles containing neuropeptides circulate in neurons' long extensions (axons) and are released at synapses. A key aspect of his work involves uncovering the molecular basis of axonal transport, which is disrupted in many neurodegenerative diseases. He has also conducted significant research on the endophilin protein, critical for maintaining prolonged synaptic activity, and studied communication between nerve cells and glial cells (support cells in the nervous system), analyzing how disruptions in this communication can increase the risk of brain cancer. Analysis of Dr. Kjærulff's publication history reveals a consistent focus on molecular neuroscience, particularly on protein function related to cellular trafficking and signaling. His work spans from basic molecular mechanisms of vesicle transport to implications for human diseases like diabetes and neurodegenerative disorders. A recurring theme is the role of specific proteins (particularly PICK1 and Rab2) in cellular processes relevant to neurological and metabolic conditions. His research combines genetic approaches in Drosophila with molecular and cellular techniques to elucidate fundamental biological processes with translational relevance. Dr. Kjærulff has held prestigious external positions including Postdoctoral Research Fellow at the Howard Hughes Medical Institute (2002) and Marie Curie Research Fellow at Karolinska Institutet (1999-2001). His laboratory utilizes Drosophila (fruit fly) as an experimental model due to its refined and efficient genetic methods, with findings having significant relevance for understanding similar processes in the human system. The Kjærulff Lab operates within the Neuropharm and Genetics research unit at the University of Copenhagen, maintaining active research programs in molecular neuroscience with connections to human disease mechanisms. His team's work has attracted media attention, with coverage in outlets discussing potential causes of growth retardation, obesity, and diabetes.